Nimotuzumab

CAS No. 828933-51-3

Nimotuzumab ( —— )

Catalog No. M22154 CAS No. 828933-51-3

Nimotuzumab is a humanized therapeutic monoclonal antibody against epidermal growth factor receptor EGFR).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity

Biological Information

  • Product Name
    Nimotuzumab
  • Note
    Research use only, not for human use.
  • Brief Description
    Nimotuzumab is a humanized therapeutic monoclonal antibody against epidermal growth factor receptor EGFR).
  • Description
    Nimotuzumab is a humanized therapeutic monoclonal antibody against epidermal growth factor receptor EGFR).
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    EGFR
  • Recptor
    EGFR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    828933-51-3
  • Formula Weight
    148 kDa
  • Molecular Formula
    ——
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Li J. Roovers, et al.Time profile of nimotuzumab for enhancing radiosensitivity of the Eca109 cell line.Oncol Lett.2019 Mar;17(3):2763-2769.
molnova catalog
related products
  • VUF 10166

    VUF10166 is a novel, potent and competitive antagonist for 5-HT3A receptor with Ki of 0.04 nM, its affinity at 5-HT3AB receptor is significantly lower.

  • Daphnetin

    Daphnetin, a natural coumarin derivative, is a protein kinase inhibitor, inhibits EGFR, PKA and PKC with IC50 of 7.67 μM, 9.33 μM and 25.01 μM, respectively, also known to exhibit anti-inflammatory and anti-oxidant activities.

  • Mutated EGFR-IN-1

    Mutated EGFR-IN-1 is a useful intermediate for the inhibitors design for mutated EGFR, such as L858R EGFR, Exonl9 deletion activating mutant, and T790M resistance mutant.